Efficacy, Pharmacokinetics, and Safety Over 48 Weeks With Ibalizumab-Based Therapy in Treatment-Experienced Adults Infected With HIV-1: A Phase 2a Study.

Gathe, Joseph C; Hardwicke, Robin L; Garcia, Fernando; Weinheimer, Steven; Lewis, Stanley T; Cash, Robert Brandon

Gathe, Joseph C; Hardwicke, Robin L; Garcia, Fernando; Weinheimer, Steven; Lewis, Stanley T; Cash, Robert Brandon.

Affiliation

Gathe JC; Therapeutic Concepts Inc., Houston, TX.
Hardwicke RL; University of Texas, John P and Katherine G McGovern Medical School, Houston, TX.
Garcia F; Texas Department of State Health Services, Victoria, TX.
Weinheimer S; TaiMed Biologics USA, Irvine, CA.
Lewis ST; TaiMed Biologics USA (previous), Irvine, CA; and.
Cash RB; Theratechnologies Inc., Medical Affairs, Montreal, Quebec, Canada .

J Acquir Immune Defic Syndr ; 86(4): 482-489, 2021 04 01.

Article in En | MEDLINE | ID: mdl-33427765

Subject(s)

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: HIV Infections / Anti-HIV Agents / Antibodies, Monoclonal Type of study: Clinical_trials Limits: Humans Language: En Journal: J Acquir Immune Defic Syndr Journal subject: SINDROME DA IMUNODEFICIENCIA ADQUIRIDA (AIDS) Year: 2021 Document type: Article

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google